Retatrutide vs Tirzepatide (Mounjaro / Zepbound)
Both are used for lose fat. Here's how they compare on human evidence, mechanism, safety and availability — in plain English.
| Retatrutide | Tirzepatide (Mounjaro / Zepbound) | |
|---|---|---|
| Human evidence | ★★★★☆ | ★★★★★ |
| Legal status | Not Approved | Prescription |
| How it works | First-in-class triple agonist — GLP1R + GIPR + glucagon receptor (GCGR). Adding glucagon-receptor agonism raises energy expenditure and hepatic fat oxidation on top of the twin appetite pathways. | Dual agonist of GIPR (GIP receptor) and GLP1R. GIP receptor activation in the hypothalamus and adipose tissue synergises with GLP-1, producing greater appetite suppression and fat loss than GLP-1 alone. |
| In plain English | Three metabolic switches in one molecule — two cut hunger, the third turns up calorie-burning. In the Phase 3 TRIUMPH-4 trial (Dec 2025) it produced 28.7% weight loss at 68 weeks — the largest ever for a drug. Not yet approved. | Hits two "I'm full" gut-hormone switches at once instead of one — so it works even better. SURMOUNT-1: 22.5% bodyweight lost, approaching bariatric-surgery territory. |
| Bottom line | The likely next leader once approved. Source: Lilly TRIUMPH-4 release. | Currently the most effective approved obesity drug. |
| Availability | Not widely approved | Prescription only |
Which is better for lose fat?
Tirzepatide (Mounjaro / Zepbound) has the stronger human-evidence rating (★★★★★ vs ★★★★☆), but the right choice still depends on your goal, tolerance and budget.
Full breakdowns: Retatrutide · Tirzepatide (Mounjaro / Zepbound).
Common questions
Is Retatrutide or Tirzepatide (Mounjaro / Zepbound) better for lose fat?
Tirzepatide (Mounjaro / Zepbound) has the stronger human-evidence rating (★★★★★ vs ★★★★☆), but the right choice still depends on your goal, tolerance and budget.
What's the difference between Retatrutide and Tirzepatide (Mounjaro / Zepbound)?
Retatrutide: The likely next leader once approved. Source: Lilly TRIUMPH-4 release. — Tirzepatide (Mounjaro / Zepbound): Currently the most effective approved obesity drug.